Human Papillomavirus (HPV) and the quadrivalent HPV Vaccine among Brazilian adolescents and parents: Factors associated with and divergences in knowledge and acceptance

Imagem de Miniatura
Arquivos
art_GOMES_Human_Papillomavirus_HPV_and_the_quadrivalent_HPV_Vaccine_2020.PDF (529.09 KB)
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2020
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
SANTOS, Edige Felipe de Sousa
KELLY, Patricia Jane
ABREU, Luiz Carlos de
Citação
PLOS ONE, v.15, n.11, article ID e0241674, 13p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Low national immunization coverage (44.64%) requires strengthening the vaccination campaign to improve knowledge about HPV and its vaccine among adolescents and parents/guardians. Our aim is to evaluate factors related to knowledge about HPV, its vaccine, acceptability and divergences among Brazilian adolescents and parents/guardians. Methods A cross-sectional study was performed at a health unit of Sao Paulo University, Brazil, from 2015 to 2016. The convenience sample comprised 1047 individuals, including 74% (n = 776) adolescents and 26% (n = 271) parents/guardians, who answered a survey (knowledge about HPV, its vaccine, barriers and acceptability). Results The main source of information for adolescents was school (39%, n = 298); for parents/guardians, it was health professionals (55%, n = 153). Parents/guardians were 2.48 times more likely than adolescents to know that HPV caused changes in the Pap smear test [RR 2.48, 95% CI 2.03-3.01 (p < 0.001)], 1.43 times likely to be aware that HPV was a sexually transmitted infection [RR 1.43, 95% CI 1.22-1.68 (p < 0.001)], and 2.77 times likely to be informed that the HPV vaccine decreased the chance of having genital warts [RR 2.77, 95% CI 2.22-2.47 (p < 0.001)]. Girls knew more about the topic than boys (RR 1.67; 95% CI 1.10-2.60); education increased parents' knowledge [(RR 3.38; 95% CI 1.71-6.69)]. Conclusion Female adolescents and parents/guardians with a higher level of education are factors related to suitable knowledge about HPV and its vaccine among Brazilian respondents. There were differences between parents/guardians and adolescents in HPV awareness, clinical implications, vaccine knowledge and vaccine acceptance.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/39287
Referências
  1. Ahmad OB, 2001, AGE STANDARDIZATION
  2. [Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y
  3. [Anonymous], 2016, STORIE LINGUAGGI, V2, P71
  4. Arrossi S, 2012, VACCINE, V30, P2467, DOI 10.1016/j.vaccine.2012.01.032
  5. Blodt S, 2012, EUR J PUBLIC HEALTH, V22, P808, DOI 10.1093/eurpub/ckr188
  6. Brasil, 1990, ESTATUTO CRIANCA ADO
  7. Brazil. Ministerio da Saude. Datasus. Informacoes de Saude, DAT INF SAUD MORB IN
  8. Brazil. Ministerio da Saude. Secretaria de Vigilancia em saude. Departamento de vigilancia de doencas transmissiveis, 2018, COORD GER PROGR NAC
  9. Brazil. Ministry of Health. Instituto Nacional de Cancer (INCA), 2020, QUEM POD SER VAC HPV
  10. Brazil-Ministerio da Saude, 2015, DATASUS VAC
  11. Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013
  12. Bruni L, 2017, LANCET GLOB HEALTH, V5, pE662
  13. Bruni L, 2019, ICO IARC INFORM CTR
  14. Carneiro RF, 2015, SANARE, V14, P104
  15. Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297
  16. De Groot AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171631
  17. Division of Cancer Prevention and Control Centers for Disease Control and Prevention, 2019, CANC ASS HUM PAP HPV
  18. Farias CC, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1677-y
  19. Figueroa-Downing D, 2017, INT J GYNECOL OBSTET, V136, P33, DOI 10.1002/ijgo.12004
  20. Freire P., 1997, EDUCACAO COMO PRATIC
  21. Fuller KM, 2017, J COMMUN HEALTH, V42, P1127, DOI 10.1007/s10900-017-0361-4
  22. Pereira JEG, 2019, CLINICS, V74, DOI 10.6061/clinics/2019/e1166
  23. Gorjana R, 2017, PREV MED, V95, P26, DOI 10.1016/j.ypmed.2016.11.019
  24. Gualano M R, 2016, J Prev Med Hyg, V57, pE121
  25. Instituto do cancer, 2019, FAK NEWS SAO EMP AUM
  26. Instituto Nacional de Cancer Jose Alencar Gomes da Silva. (INCA/MS), 2015, TIP CANC COL UT
  27. Kornfeld J, 2013, J PRIM PREV, V34, P59, DOI 10.1007/s10935-013-0297-0
  28. Kose D, 2014, ASIAN PAC J CANCER P, V15, P7263, DOI 10.7314/APJCP.2014.15.17.7263
  29. Markowitz LE, 2014, MMWR RECOMM REP, V63, P1
  30. Nogueira-Rodrigues A, 2017, CANCER-AM CANCER SOC, V123, P2193, DOI 10.1002/cncr.30647
  31. OPAS/WHO, 1978, C INT CUID PRIM SAUD
  32. Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
  33. Patel H, 2016, SEX TRANSM INFECT, V92, P474, DOI 10.1136/sextrans-2015-052341
  34. SAEDE: Portal de estatisticas de SAo Paulo, SAEDE PORT EST SAO P
  35. Silva ATM, 2017, J HUM GROWTH DEV, V27, P117, DOI 10.7322/JHGD.127686
  36. Sorpreso ICE, 2018, J HUM GROWTH DEV, V28, P5, DOI [10.7322/jhgd.143887, DOI 10.7322/JHGD.143887]
  37. Sousa PDL, 2018, J HUM GROWTH DEV, V28, P58, DOI [10.7322/jhgd.143856, DOI 10.7322/JHGD.143856]
  38. Tafuri S, 2014, VACCINE, V32, P4860, DOI 10.1016/j.vaccine.2013.11.006
  39. The Lancet HIV, 2017, LANCET HIV, V4, pe51
  40. Voidazan S, 2016, CENT EUR J PUBL HEAL, V24, P29, DOI 10.21101/cejph.a4287
  41. World Health Organization (WHO), 2017, WKLY EPIDEMIOL REC, V92, P241, DOI 10.1016/j.vaccine.2017.05.069

Coleções
Artigos e Materiais de Revistas Científicas - FM/MOG
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/58